cdn mobile

City health officer: Residents bitten by rabid dog expected to recover

By: Dominic D. Yasay January 23,2017 - 01:39 PM

Victims receive anti-rabies shots today at Mandaue City Health Center (CDN PHOTO/ DOMINIC YASAY)

Victims receive anti-rabies shots today at Mandaue City Health Center (CDN PHOTO/ DOMINIC YASAY)

The 22 residents of Barangay Casuntingan in Mandaue City who were attacked by a rabid dog last Saturday are in a stable condition and have began undergoing the injection of anti-rabies shots on Monday morning.

During a press conference earlier, Mandaue City Health Office head Edna Seno said that no patients were in danger.

“There is no imminent danger for transmitting it to other residents,” Seno told reporters.

The residents, majority of them sustained bite wounds on their legs and thighs. Anti-rabies treatment will continue for a month.

They were advised to not drink alcoholic drinks for 28 days while they are undergoing treatment.

Seno said that the city has an ample supply of medicine for the victims.

Mandaue City mayor Luigi Quisumbing urged the public to cooperate with the local government to prevent the recurrence of the incident by giving them information on any suspicious animals in their barangays.

This is the first time that Mandaue has had this many residents attacked by a rabid stray animal.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: Barangay Casuntingan, Mandaue City
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.